In this study, we demonstrated that ACh has functional effects in breast cancer cell lines—specifically, activating the MAPK/ERK and PI3K/Akt pathways, inducing p-ERα, and eliciting its nuclear translocation. Here, ESR1 is linked to breast carcinoma.